Exercise can reduce drug-related joint pain in breast cancer patients
A study by Dr. Jennifer Ligibel, Dana-Farber Cancer Institute (pictured), shows exercise can reduce drug-related joint pain in breast cancer patients.
A study by Dr. Jennifer Ligibel, Dana-Farber Cancer Institute (pictured), shows exercise can reduce drug-related joint pain in breast cancer patients.
Patients with COPD have trouble pushing used air out of their lungs, making it difficult to take in healthy new air. Although there is no cure for COPD,… read more.
Solange M Sanches et al, AC Camargo Cancer Center, São Paulo, Brazil.
Discussion of the abstract by Dr Christopher Lieu, MD, Assistant professor at the University of Colorado. Younger patients with colorectal cancer that has spread (metastasised) to other parts… read more.
Birgitte Pedersen et al, Vejle Hospital, Denmark. Patients with colorectal cancer (CRC) face huge challenges in their everyday lives as a result of their condition and treatments.
Discussion of the abstract by Professor Philippe Autier, Vice President, Population Studies, at the International Prevention Research Institute, Lyon, France.
Discussion of the abstract by Dr Zoran Gatalica, Adjunct Professor of Pathology at Creighton University School of Medicine .
Oral discussion of abstract by Professor Naredi, Sahlgrenska University Hospital, Gothenburg, Sweden. Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer.
by Peter Mas Mollinedo – Improvements in diagnostics and medical treatments mean the number of patients living with cancer is increasing around the world. The World Health Organization… read more.
by Peter Mas Mollinedo reporting on the presentation by Dominique Elias, Gustave-Roussy Institute, Paris, France. – Aggressive complete cytoreductive surgery (CCRS) in combination with hyperthermic intraperitoneal chemotherapy (HIPEC)… read more.
LM Wiltink, Leiden University Medical Center, the Netherlands; Hans-Joachim Schmoll, Martin Luther University Halle – Wittenberg, Germany. A unique 14-year follow-up study from the universities of Leiden in… read more.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Anti-clotting agent helps reduce the risk of intraprocedural events during percutaneous coronary intervention.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.